Alpha-fetoprotein is a ~70 kDa glycoprotein synthesized primarily by the fetal liver and yolk sac during embryogenesis, functioning as a carrier protein and immunomodulatory molecule involved in fetal homeostasis and development. Following birth, AFP expression declines dramatically and remains at very low levels in healthy adults; re-expression is strongly associated with malignant transformation, particularly in hepatocellular carcinoma and germ cell tumors. From a molecular perspective, AFP belongs to the albuminoid family and interacts with diverse ligands, including fatty acids and steroids, contributing to immune regulation and cellular signaling pathways linked to proliferation, apoptosis, and metastasis. These biological properties explain why AFP is considered a prototypical tumor-associated fetal antigen and a clinically valuable biomarker across oncology.

Diagnostic Utility of Alpha-fetoprotein (AFP) in Genitourinary Pathology

• AFP immunoreactivity plays a pivotal role in the diagnosis of germ cell tumors, especially yolk sac tumors and mixed germ cell neoplasms of the testis.
• AFP production reflects embryonic endodermal differentiation, making it a key marker for identifying yolk sac tumor components and related histologies.
• Peer-reviewed immunohistochemical studies demonstrate that AFP staining can localize tumor-derived protein within germ cell tumor tissue, supporting morphologic assessment and aiding differential diagnosis between embryonal carcinoma, mixed germ cell tumors, and other AFP-producing malignancies.
• AFP lacks absolute specificity and may be expressed in certain non-hepatic tumors or rare urothelial carcinomas, but its combined interpretation with clinical, morphologic, and additional immunomarkers improves diagnostic precision.
• AFP IHC remains an important ancillary tool for pathologists evaluating genitourinary lesions with enteroblastic, hepatoid, or yolk sac–like differentiation.

Key Features of Anti-Alpha-fetoprotein (AFP) CE/IVD Antibodies

• High analytical sensitivity and specificity: AFP’s stable structure and conserved domains facilitate reliable antigen recognition under varied laboratory conditions, which is advantageous for clinical immunoassays and tissue-based detection.
• Compatibility with FFPE tissues: AFP’s structural stability and well-characterized epitopes allow consistent immunohistochemical staining in diagnostic samples.
• Clinical relevance in oncology diagnostics: AFP is widely recognized as a tumor marker for germ cell tumors and other malignancies, supporting the clinical value of validated antibody reagents.
• Support for standardized pathology workflows: CE/IVD labeling indicates conformity with regulated diagnostic standards, facilitating reproducible biomarker evaluation in translational research and routine clinical practice.